These patients deserve better

Discussion in 'Mitsubishi Tanabe Pharma' started by anonymous, Oct 30, 2017 at 12:29 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Every stakeholder has different data and can't communicate with each other, it's the blind leading the blind, and they wonder why there are 600 patients that are stuck in process. Unblind the team so they can work together and solve issues blocking patients access.
     

  2. anonymous

    anonymous Guest

    tru dat
     
  3. anonymous

    anonymous Guest

    20 more Reimbursement managers need to be added. Not nearly enough for such a mess at the Hub and with general access. Field sales job is to generate Rxs. That's all they should worry about and focus on.
     
  4. anonymous

    anonymous Guest

    A "team" doesn't really exist. Several silos
    You have entire states not only unwilling to write this dog of a drug, but that actively lobby against its use
    Look at social media. Hundreds of posts a day and not a single person responsible for putting a positive message out there. Conferences that leadership attends where they misspeak about and actively discourage use of the med and they sit there and say what a great talk it was
    You have a sales force that could not sell candy to a baby and RBDs that hire the same sort of NAS over and over...
    Any person with a sliver of talent is long gone
    Wake up!
     
  5. anonymous

    anonymous Guest

    What about hiring practices? Rare disease will only take MT so far.. we need sales people. we need leaders who will treat the organization like a start-up.. we need sales people who will actually network with social workers, caseworkers, nurses, etc.. All clinical sell - Get over yourself Adam! look where it's gotten the organization in 3 years.
     
  6. anonymous

    anonymous Guest

    These patients will never get better until something better exists
     
  7. anonymous

    anonymous Guest

    that's tremendous insight

    a terminal disease and patients won't get better

    unless a cure comes along

    that would be something better

    Harvard, right?
     
  8. anonymous

    anonymous Guest

    Are you suggesting this product is helpful on any level?
    Are you reading what is currently in print from patients? How about the medical community?
    You don’t need Harvard for this, which is obvious when you look at who’s around this place.
    But just keep on with your smug self.
     
  9. anonymous

    anonymous Guest

    Must agree. JH left because extension data and its presentation is trash. When you’re paying a doctor and they can’t support you, you have nothing.